不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>行业动态>Inovio与Plumbline Life Sciences开展动物保健合作

Inovio与Plumbline Life Sciences开展动物保健合作

美通社2019年5月16日 9:45 点击:211

Inovio Pharmaceuticals Inc. 和Plumbline Life Sciences 今天宣布,就联合开发针对非洲猪瘟(ASF)病毒的创新动物保健疫苗达成合作。

不用本金就能赚钱的方法BINXIFANIYAZHOUPULIMAOSIHUIYIHEHANGUOSHOUER2019NIAN5YUE15RI /MEITONGSHE/ -- Inovio Pharmaceuticals Inc. (NASDAQ: INO)HEPlumbline Life Sciences (XKRX: 222670)JINTIANXUANBU,JIULIANHEKAIFAZHENDUIFEIZHOUZHUWEN(ASF)BINGDUDECHUANGXINDONGWUBAOJIANYIMIAODACHENGHEZUO。XINYIMIAOJIANGLIYONGInovioDESynCon®JISHUKAIFA,BINGLIYONGCELLECTRA®DISONGZHUANGZHIJINXINGJIYAO。ZONGBUWEIYUHANGUODEPlumblineJIANGTIGONGFEIZHOUZHUWENYIMIAODESUOYOUKAIFAYUSHANGYETUIGUANGFEIYONG。InovioHEPlumblineYIJINGZAIDONGWUBAOJIANLINGYUJIANLILESHOUQUANHEZUOGUANXI,MUQIANInovioCHIYOUPlumblineYUE15%DEGUQUAN。GENJUHEZUOXIEYITIAOKUAN,InovioJIANGZAIXIAODONGWUMOXINGZHONGKAIFABINGCESHIFEIZHOUZHUWENYIMIAO。PlumblineJIANGZAIDAXINGDONGWUMOXINGZHONGJINYIBUCESHIYIMIAO,BAOKUOZHUGANRANMOXING,BINGJINYIBUKAIFA,YIBIANSHIXIANYIMIAODESHANGYONG。SHUANGFANGBINGMEIYOUTOULUCAIWUANPAI。

FEIZHOUZHUWENSHIYIZHONGBINGDUSUOYINQIDEZHUBING,BIAOXIANWEICHUXUERE,DUIJIAZHUHEYEZHUJUNYOUHENGAODECHUANRANXING,YIJINGZAOCHENGYANZHONGDEJINGJIHESHENGCHANSUNSHI。MUQIANSHIMIANSHANGHAIMEIYOUYIHUOPIDEFEIZHOUZHUWENYIMIAO,YAZHOUMUQIANDEYIQINGBAOFAZHENGYANZHONGWEIXIEDAOYAZHOUXUDUOGUOJIADENONGYEJINGJI,BAOKUOZHONGGUO、YUENANHEHANGUO。ZHEIZHONGJIBINGZAIZHUSHENSHANGWUFAZHIYU,DANDUIRENLEIWUHAI。

不用本金就能赚钱的方法InovioGONGSIDESHOUXIKEXUEGUANLaurent HumeauBIAOSHI:“WOMENHENGAOXINGLIYONGInovioGONGSIDESynthetic NucleicsPINGTAI,KAIFAYIMIAOLAIDUIKANGZHEIZHONGZHIMINGDEZHUBINGDU。InovioZAIKAIFAXINXINGCHUANRANBINGYIMIAOFANGMIANYIZHIBIAOXIANCHUSE,WOMENHENGAOXINGYUPlumblineHEZUO,JINYIBUCESHIFEIZHOUZHUWENYIMIAOBINGJIANGQISHANGYONG。”

PlumblineGONGSIZONGCAIJIANSHOUXIZHIXINGGUANAnthony K. KimBIAOSHI:“PlumblineGONGSIHENGAOXINGYUInovioGONGSIXIESHOUKAIFAYIZHONGXINDEYIMIAO,LAIYINGDUIZHEIZHONGYANZHONGWEIXIEDONGWUJIANKANGHENONGYESHIPINGONGYINGDEBINGDU。PlumblineZAIJIANGJIYUDNADEDONGWUJIANKANGLIAOFASHANGYONGFANGMIANYOUZHELIANGHAODEJILU,WOMENZHENDUIZHUDECHANPINLifeTide®SW5YIJINGZAIAODALIYA、XINXILANHEHANGUOHUODEJIANGUANBUMENDEPIZHUN。WOMENJIANGJIEJINQUANLIJINKUAISHIXIANFEIZHOUZHUWENYIMIAODESHANGYONG。”

GUANFANGSHUJUGUJI,ZHONGGUOYIJINGZAISHALE100WANTOUSHENGZHU,DANTUZAISHUJUXIANSHI,ZHONGGUO4.4YITOUSHENGZHUDESHULIANGKENENGHUIZAI2019NIANJIANSHAO1YITOUYISHANG。MEIGUONONGYEBUJINNIAN4YUEYUCE,ZHONGGUODESHENGZHUSHULIANGJIANGJIANSHAO1.34YITOU,XIANGDANGYUMEIGUOSHENGZHUNIANCHANLIANGDEZONGHE。ZHEISHIMEIGUONONGYEBU20SHIJI70NIANDAIZHONGQIKAISHITONGJIZHONGGUOSHENGZHUSHULIANGYILAIZUIYANZHONGDEYICIXIADIE。

FEIZHOUZHUWENBINGDUYUANCHANYUFEIZHOU,ZHIGANRANJIAZHU、YEZHUHEXIEDAIZHEIZHONGJIBINGDERUANPI。ZHEIZHONGJIBINGJISHINIANQIANZAIFEIZHOUCHUXIAN,XIANZAIYIJINGCHUXIANZAIOUZHOUDEJIAZHUHEYEZHUSHENSHANG。2007NIAN,ZHEIZHONGBINGDUXINGJIBINGCHUXIANZAIGELUJIYAGONGHEGUO,BINGZAIGAOJIASUODIQUMANYAN,ZUIZHONGYU2018NIAN8YUECHUANRUZHONGGUO,RANHOUZAIJINNIAN1YUECHUANDAOMENGGU,2YUECHUANDAOYUENAN。RIBENZAI3YUEDIFAXIANLESHOULIFEIZHOUZHUWENGANRANBINGLI。ZAIYAZHOUMANYANDEFEIZHOUZHUWENDUZHUSHIGAODUZHIMINGDE,TAGANRANDEMEIYITOUZHUDOUSIYUCHUXUEXINGJIBING,LINGRENBUJINXIANGQIRENLEIGANRANAIBOLABINGDUDEQINGJING,JINGUANFEIZHOUZHUWENBINGDUBUHUIDAOZHIRENLEISHENGBING。

Plumbline Life Sciences, Inc简介

DONGWUSHENGWUZHIYAOGONGSIPlumbline Life Sciences, Inc.ZHUANZHUYUBANLVDONGWUDEJIANKANG。GAIGONGSIKAIFALETUOYANGHETANGHESUAN(DNA)WEIJICHUDEDONGWUYIMIAOHELIAOFA,TONGGUODIANCHUANKONG,SHIYONGZHILIWEIJICHUDEDNAJIYAOHEBIAODAJISHU,CONGERYOUHUADONGWUDEZIRANSHENGWUHEMIANYIQIANLI。GAIGONGSIDEJIEJUEFANGANBAOKUOTIANRANCUNZAIDEFENZISHENGZHANGJISUSHIFANGJISU(GHRH);YIJIJIANGZHILIDAORUGUGEJIXIBAOHEPIFUDEDIANCHUANKONGJISHU。GAIGONGSIDECHANPINYONGYUZHILIAOXIAOGOUAIZHENG/PINXUE、MATIYEYAN、MAOSHENGONGNENGSHUAIJIE/PINXUE、XIAOGOUSHENGONGNENGSHUAIJIE/PINXUEHEZHUCUSHENGZHANGJISUSHIFANGJISU。Plumbline Life Sciences, Inc.ZONGBUWEIYUHANGUOSHOUER。

Inovio Pharmaceuticals, Inc简介

Inovio是一家创新的生物技术公司,专注于人造核酸技术的发现、开发和商业化,从而对抗癌症和传染疾病。Inovio的专有技术平台采用了抗原测序和递送技术,用于激活针对目标疾病的强大免疫反应。该技术仅在体内发挥作用,并且已被证明能够持续激活针对靶向癌症和病原体的稳健且功能完全的T细胞和抗体反应。Inovio最先进的临床项目VGX-3100处于治疗HPV(人乳头瘤病毒)相关宫颈癌前病变的第三期。同时正在开发的还有针对HPV相关癌症、膀胱癌和胶质母细胞瘤的二期免疫肿瘤学计划,以及乙型肝炎、寨卡病毒、埃博拉病毒、中东呼吸综合征(MERS)和艾滋病毒(HIV)的平台开发计划。合作伙伴及合作者包括:阿斯利康(AstraZeneca)、再生元(Regeneron)、罗氏/基因泰克(Roche/Genentech)、北京东方略生物医药科技有限公司、GeneOne Life Science、比尔及梅琳达-盖茨基金会(The Bill & Melinda Gates Foundation)、流行病防范创新联盟(CEPI)、帕克癌症免疫疗法研究所(Parker Institute for Cancer Immunotherapy)、美国国防高级研究计划局(DARPA)、美国国立卫生研究院(NIH)、美国国家过敏症和传染病研究所(National Institute of Allergy and Infectious Diseases)、美国国家癌症研究所(National Cancer Institute)、艾滋病疫苗试验网络(HIV Vaccines Trial Network)、美国华尔特-里德陆军研究院(Walter Reed Army Institute of Research)、威斯达研究所(The Wistar Institute)和宾夕法尼亚大学(University of Pennsylvania)。详情请访问:。

BENXINWENGAOHANYOUYUGAIGONGSIYEWUXIANGGUANDEMOUXIEQIANZHANXINGCHENSHU,QIZHONGBAOKUOGAIGONGSIKAIFAJIYUDNADEMIANYILIAOFADEJIHUA;DUIYANFAJIHUADEYUQI,LIRUJIHUAQIDONGHEZHANKAILINCHUANGSHIYAN,YIJIZHEIXIESHIYANSHUJUDEKEYONGXINGHESHIJIANANPAI。YOUYUZHUDUOYINSUDECUNZAI,SHIJISHIJIANHUOJIEGUOKENENGYUWENZHONGSUOSHUDEYUQIBUTONG,BAOKUOLINCHUANGQIANYANJIU、LINCHUANGSHIYANHECHANPINKAIFAJIHUABENSHENCUNZAIDEBUQUEDINGXING;WEIZHENGMINGDIANCHUANKONGJISHUKEANQUANYOUXIAODIYONGZUODISONGJIZHIHUOKAIFAKEXINGDEDNAYIMIAO,CHIXUJINXINGYANJIUSUOXUZIJINDEKEYONGXING;GAIGONGSINENGFOUZHICHISynCon®ZHUDONGMIANYILIAOFAHEYIMIAOCHANPINYANFAGUANXIAN;GAIGONGSIHEZUOZHEZAIGONGSISUOSHOUQUANCHANPINDEKAIFAHESHANGYEHUA,YIJICHANPINXIAOSHOUSHANGNENGFOUQUDELICHENGBEISHICHENGJIU,CONGERSHIGAIGONGSINENGSHOUDAOWEILAIKUANXIANGHETEXUQUANSHIYONGFEI;GAIGONGSIZIBENZIYUANDECHONGZUXING;TIDAILIAOFAHUOZHEGAIGONGSIHUOHEZUOZHESUOCEZHONGDEBINGZHENGLIAOFADEKEYONGXINGHUOQIANZAIKEYONGXING,BAOKUOKENENGBIGAIGONGSIYUHEZUOZHEXIWANGKAIFACHUDERENHELIAOFAHUOZHILIAOFANGANGENGYOUXIAOHUOGENGJUCHENGBENXIAOYIDETIDAIFANGAN;SHEJICHANPINZERENDEWENTI、SHEJIZHUANLIDEWENTI,YIJITAMENHUODUITAMENDESHOUQUANNENGFOUYOUXIAOBAOHUGAIGONGSIBUSHOUSHIYONGXIANGGUANJISHUDETARENDEQINHAI;ZHEIXIESUOYOUQUANSHIFOUKEQIANGZHISHISHI、ZHENGDANGKEKAO,HUOZHEQINFANHUOSHEXIANQINFANTARENDEQUANLI,HUOKEYICHENGSHOUWUXIAOSUOPEI;YIJIGAIGONGSISHIFOUKEYIWEIQISU、BAOHUHUOHANWEIZHEIXIEQUANLITIGONGSUOXUDEZIJINHUOQITAZHONGYAOZIYUAN;QIYEZHICHUSHUIPING;QIANZAIDEQIYEHUOQITAHEZUOHUOBANHUOHEZUOZHEDUIGAIGONGSIJISHUDEPINGGU;ZIBENSHICHANGTIAOJIAN;ZHENGFUDUIYILIAOBAOJIANXINGYEDETIANDEYINGXIANG;YIJIGAIGONGSIJIEZHI2018NIAN12YUE31RIDE10-KBIAONIANDUBAOGAO,GAIGONGSIJIEZHI2019NIAN3YUE31RIDE10-QBIAOJIDUBAOGAO,YIJIGAIGONGSIBUSHITIJIAOJIMEIGUOZHENGQUANJIAOYIWEIYUANHUIDEWENJIANSUOCHANSHUDEQITAYINSUDEYINGXIANG。WUFABAOZHENGGAIGONGSIYANFAGUANXIANZHONGRENHEHOUXUANCHANPINNENGGOUCHENGGONGKAIFA、SHENGCHANHUOSHANGYEHUA;LINCHUANGSHIYANDEZUIZHONGJIEGUOJIANGZHICHIXIAOSHOUCHANPINSUOXUDEJIANGUANPIZHUN,HUOZHEWENZHONGRENHEQIANZHANXINGXINXIJIANGBEIZHENGMINGSHIZHUNQUEDE。QIANZHANXINGCHENSHUJINDAIBIAOBENXINWENGAOFABUZHIRIDEQINGKUANG,CHUFEIFALVYAOQIU,FOUZEGAIGONGSIGAIBUCHENGDANGENGXINHUOXIUDINGZHEIXIECHENSHUDEYIWU。

 

联系人


投资者

Ben Matone,484-362-0076,ben.matone@inovio.com

媒体

Jeff Richardson,267-440-4211,jrichardson@inovio.com

 

消息来源:Inovio Pharmaceuticals, Inc.


(来源: 美通社


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com不用本金就能赚钱的方法

BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。
湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图